Globalization and Pharmaceutical Industry:The Ethical Dimension of Health Care.

Abstract

Currently, the pharmaceutical industry is one of the most profitable industrial, business and commercial sectors at a global level, whose growth is due to interaction with globalization and the versatility it has had when it comes to integrating into global markets. In its historical evolution, it has gone from cataloging the benefits of various chemical substances found in plants, to defining and determining the scope of medical practice. However, commercial logic has led to the merger of various pharmaceutical companies, whose purpose is to boost the economy, monopolies and oligopolies, to the detriment of population health, which is determined by the levels of economic accessibility of the countries, which means give preferences to the access of medicines to the Global North, causing the widening of social asymmetries in peripheral countries. With this, the right to health is dismantled, which indicates the urgency of returning the human side to this industry, rethinking its objectives and dimensioning it from an ethical and critical perspective.